Abstract
Purpose:
To explore the incidence, signs and symptoms, causes and prognosis of anaphylactoid reactions in PICC catheterization.
Methods:
Prospectively observe the occurrence of anaphylactoid reactions in coated and uncoated PICC during insertion from November 2018 to April 2020. A diagnosis of anaphylactoid reactions was based on the signs and symptoms and laboratory results, and then collect data for analysis.
Results:
A total of 1439 coated catheters were inserted, of which 30 resulted in anaphylactoid reactions (2.08%). The signs and symptoms were mainly skin system symptoms, combined with respiratory, cardiovascular, and digestive system symptoms. The anaphylactoid reaction rates of coated catheters were higher than those of uncoated catheters (χ2 = 38.417, 19.352, p < .01). A 29 of 30 patients completed catheterization after symptoms were resolved, these catheters were removed after treatment completion. Catheterization was terminated in one patient. There were no anaphylactoid reactions in 2850 uncoated catheters.
Conclusion:
Anaphylactoid reactions may occur during catheterization when using the coated PICC, which should be paid attention to in clinical application.
Get full access to this article
View all access options for this article.